Main > ONCOLOGY (**) > Lymphoma>NHL>Auto. Transplant.*** > Co: FR. S. Plerixafor Inj.+G-CSF

---

Co: FR. S. Plerixafor Inj.+G-CSF's subsections
(*) USA Approval Date: 2008. 12.16.
Company
CXCR4 Receptor AntAgonist
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2009. 06.30
TradeMark (Plerixafor)
TradeMark (Plerixafor) Web-Site USA

Co: FR. S. Plerixafor Inj.+G-CSF's products
This section has no products